Ming‐Chi Lu

机构：Tzu Chi University, Tzu Chi Foundation · ORCID：0000-0001-9051-0351

发表论文 331 篇 · 总被引 11028 次 · h-index 44

代表论文

• TRAILBLAZER‐ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease (2025 · Alzheimer s & Dementia · 被引 27)
• Hu Gan Tang ameliorates metabolic-associated fatty liver disease by inhibiting ferroptosis through the Nrf2/GPX4 pathway (2025 · Journal of Ethnopharmacology · 被引 6)
• Development and validation of an integrative 54 biomarker-based risk identification model for multi-cancer in 42,666 individuals: a population-based prospective study to guide advanced screening strategies (2025 · Biomarker Research · 被引 5)
• MALMPS: A Machine Learning‐Based Metabolic Gene Prognostic Signature for Stratifying Clinical Outcomes and Molecular Heterogeneity in Stage II/III Colorectal Cancer (2025 · Advanced Science · 被引 5)
• The Relationship Between TNF‐α Inhibitor Potency and HBV Reactivation in Patients With Rheumatic Disorders (2025 · Liver International · 被引 4)
• Clinical validation of the Lilly SP‐X P‐tau217 assay: Performance in underrepresented cohorts (2025 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 被引 3)